Craving in Alcohol-Dependent Patients After Detoxification Is Related to Glutamatergic Dysfunction in the Nucleus Accumbens and the Anterior Cingulate Cortex
The upregulation of glutamatergic excitatory neurotransmission is thought to be partly responsible for the acute withdrawal symptoms and craving experienced by alcohol-dependent patients. Most physiological evidence supporting this hypothesis is based on data from animal studies. In addition, clinic...
Saved in:
Published in | Neuropsychopharmacology (New York, N.Y.) Vol. 38; no. 8; pp. 1401 - 1408 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basingstoke
Nature Publishing Group
01.07.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The upregulation of glutamatergic excitatory neurotransmission is thought to be partly responsible for the acute withdrawal symptoms and craving experienced by alcohol-dependent patients. Most physiological evidence supporting this hypothesis is based on data from animal studies. In addition, clinical data show that GABAergic and anti-glutamatergic drugs ameliorate withdrawal symptoms, offering indirect evidence indicative of glutamatergic hyperexcitability in alcohol-dependent subjects. We used proton magnetic resonance spectroscopy to quantify the glutamate (Glu) levels in healthy control subjects and in alcohol-dependent patients immediately after detoxification. The volumes of interest were located in the nucleus accumbens (NAcc) and the anterior cingulate cortex (ACC), which are two brain areas that have important functions in reward circuitry. In addition to Glu, we quantified the levels of combined Glu and glutamine (Gln), N-acetylaspartate, choline-containing compounds, and creatine. The Glu levels in the NAcc were significantly higher in patients than in controls. Craving, which was measured using the Obsessive Compulsive Drinking Scale, correlated positively with levels of combined Glu and Gln in the NAcc and in the ACC. The levels of all other metabolites were not significantly different between patients and controls. The increased Glu levels in the NAcc in alcohol-dependent patients shortly after detoxification confirm the animal data and suggest that striatal glutamatergic dysfunction is related to ethanol withdrawal. The positive correlation between craving and glutamatergic metabolism in both key reward circuitry areas support the hypothesis that the glutamatergic system has an important role in the later course of alcohol dependence with respect to abstinence and relapse. |
---|---|
AbstractList | The upregulation of glutamatergic excitatory neurotransmission is thought to be partly responsible for the acute withdrawal symptoms and craving experienced by alcohol-dependent patients. Most physiological evidence supporting this hypothesis is based on data from animal studies. In addition, clinical data show that GABAergic and anti-glutamatergic drugs ameliorate withdrawal symptoms, offering indirect evidence indicative of glutamatergic hyperexcitability in alcohol-dependent subjects. We used proton magnetic resonance spectroscopy to quantify the glutamate (Glu) levels in healthy control subjects and in alcohol-dependent patients immediately after detoxification. The volumes of interest were located in the nucleus accumbens (NAcc) and the anterior cingulate cortex (ACC), which are two brain areas that have important functions in reward circuitry. In addition to Glu, we quantified the levels of combined Glu and glutamine (Gln), N-acetylaspartate, choline-containing compounds, and creatine. The Glu levels in the NAcc were significantly higher in patients than in controls. Craving, which was measured using the Obsessive Compulsive Drinking Scale, correlated positively with levels of combined Glu and Gln in the NAcc and in the ACC. The levels of all other metabolites were not significantly different between patients and controls. The increased Glu levels in the NAcc in alcohol-dependent patients shortly after detoxification confirm the animal data and suggest that striatal glutamatergic dysfunction is related to ethanol withdrawal. The positive correlation between craving and glutamatergic metabolism in both key reward circuitry areas support the hypothesis that the glutamatergic system has an important role in the later course of alcohol dependence with respect to abstinence and relapse. The upregulation of glutamatergic excitatory neurotransmission is thought to be partly responsible for the acute withdrawal symptoms and craving experienced by alcohol-dependent patients. Most physiological evidence supporting this hypothesis is based on data from animal studies. In addition, clinical data show that GABAergic and anti-glutamatergic drugs ameliorate withdrawal symptoms, offering indirect evidence indicative of glutamatergic hyperexcitability in alcohol-dependent subjects. We used proton magnetic resonance spectroscopy to quantify the glutamate (Glu) levels in healthy control subjects and in alcohol-dependent patients immediately after detoxification. The volumes of interest were located in the nucleus accumbens (NAcc) and the anterior cingulate cortex (ACC), which are two brain areas that have important functions in reward circuitry. In addition to Glu, we quantified the levels of combined Glu and glutamine (Gln), N -acetylaspartate, choline-containing compounds, and creatine. The Glu levels in the NAcc were significantly higher in patients than in controls. Craving, which was measured using the Obsessive Compulsive Drinking Scale, correlated positively with levels of combined Glu and Gln in the NAcc and in the ACC. The levels of all other metabolites were not significantly different between patients and controls. The increased Glu levels in the NAcc in alcohol-dependent patients shortly after detoxification confirm the animal data and suggest that striatal glutamatergic dysfunction is related to ethanol withdrawal. The positive correlation between craving and glutamatergic metabolism in both key reward circuitry areas support the hypothesis that the glutamatergic system has an important role in the later course of alcohol dependence with respect to abstinence and relapse. The upregulation of glutamatergic excitatory neurotransmission is thought to be partly responsible for the acute withdrawal symptoms and craving experienced by alcohol-dependent patients. Most physiological evidence supporting this hypothesis is based on data from animal studies. In addition, clinical data show that GABAergic and anti-glutamatergic drugs ameliorate withdrawal symptoms, offering indirect evidence indicative of glutamatergic hyperexcitability in alcohol-dependent subjects. We used proton magnetic resonance spectroscopy to quantify the glutamate (Glu) levels in healthy control subjects and in alcohol-dependent patients immediately after detoxification. The volumes of interest were located in the nucleus accumbens (NAcc) and the anterior cingulate cortex (ACC), which are two brain areas that have important functions in reward circuitry. In addition to Glu, we quantified the levels of combined Glu and glutamine (Gln), N-acetylaspartate, choline-containing compounds, and creatine. The Glu levels in the NAcc were significantly higher in patients than in controls. Craving, which was measured using the Obsessive Compulsive Drinking Scale, correlated positively with levels of combined Glu and Gln in the NAcc and in the ACC. The levels of all other metabolites were not significantly different between patients and controls. The increased Glu levels in the NAcc in alcohol-dependent patients shortly after detoxification confirm the animal data and suggest that striatal glutamatergic dysfunction is related to ethanol withdrawal. The positive correlation between craving and glutamatergic metabolism in both key reward circuitry areas support the hypothesis that the glutamatergic system has an important role in the later course of alcohol dependence with respect to abstinence and relapse.The upregulation of glutamatergic excitatory neurotransmission is thought to be partly responsible for the acute withdrawal symptoms and craving experienced by alcohol-dependent patients. Most physiological evidence supporting this hypothesis is based on data from animal studies. In addition, clinical data show that GABAergic and anti-glutamatergic drugs ameliorate withdrawal symptoms, offering indirect evidence indicative of glutamatergic hyperexcitability in alcohol-dependent subjects. We used proton magnetic resonance spectroscopy to quantify the glutamate (Glu) levels in healthy control subjects and in alcohol-dependent patients immediately after detoxification. The volumes of interest were located in the nucleus accumbens (NAcc) and the anterior cingulate cortex (ACC), which are two brain areas that have important functions in reward circuitry. In addition to Glu, we quantified the levels of combined Glu and glutamine (Gln), N-acetylaspartate, choline-containing compounds, and creatine. The Glu levels in the NAcc were significantly higher in patients than in controls. Craving, which was measured using the Obsessive Compulsive Drinking Scale, correlated positively with levels of combined Glu and Gln in the NAcc and in the ACC. The levels of all other metabolites were not significantly different between patients and controls. The increased Glu levels in the NAcc in alcohol-dependent patients shortly after detoxification confirm the animal data and suggest that striatal glutamatergic dysfunction is related to ethanol withdrawal. The positive correlation between craving and glutamatergic metabolism in both key reward circuitry areas support the hypothesis that the glutamatergic system has an important role in the later course of alcohol dependence with respect to abstinence and relapse. |
Author | Ohrmann, Patricia Scherbaum, Norbert Pedersen, Anya Bauer, Jochen Patschke, Johanna Bening, Johanna Kugel, Harald Heindel, Walter Arolt, Volker |
Author_xml | – sequence: 1 givenname: Jochen surname: Bauer fullname: Bauer, Jochen – sequence: 2 givenname: Anya surname: Pedersen fullname: Pedersen, Anya – sequence: 3 givenname: Norbert surname: Scherbaum fullname: Scherbaum, Norbert – sequence: 4 givenname: Johanna surname: Bening fullname: Bening, Johanna – sequence: 5 givenname: Johanna surname: Patschke fullname: Patschke, Johanna – sequence: 6 givenname: Harald surname: Kugel fullname: Kugel, Harald – sequence: 7 givenname: Walter surname: Heindel fullname: Heindel, Walter – sequence: 8 givenname: Volker surname: Arolt fullname: Arolt, Volker – sequence: 9 givenname: Patricia surname: Ohrmann fullname: Ohrmann, Patricia |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27477718$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23403696$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkl1rVDEQhoNU7IdeeS8BEQQ5a3KSk5PcCMuu1kJREYXehWxOspuSTbZJTml_jP_V7HbrR_HCqyF5n3kzk5ljcBBiMAA8x2iCEeFvw2YzaREmE9o9Ake4p6hhhF4cgCPEBWkwIReH4DjnS4Rw1zP-BBy2hCLCBDsCP2ZJXbuwhC7AqddxFX0zNxsTBhMK_KKKqzHDqS0mwbkp8cZZp-t1DPAsw6_Gq2IGWCI89WNR63pKS6fh_DbbMegdV63LysBPo_ZmrF5aj-uFCRmqMOyUaahZLiY4q5WMW0c4i6mYm6fgsVU-m2f7eAK-f3j_bfaxOf98ejabnje6I7w0qh9aojojesoNHRiyC9NaqwxBrPaprLXdQoiqd23f8YF0SnRYaczYwGnFTsC7O9_NuFibQdeek_Jyk9xapVsZlZN_K8Gt5DJeS8J4iymuBq_3BilejSYXuXZZG-9VMHHMEhMhBBYIsf9AWc85wryv6MsH6GUcU6g_saWYoIKS7dsv_iz-V9X3Q67Aqz2gslbeJhW0y7-5nvZ9j3nl8B2nU8w5GSu1K7tR156dlxjJ7cLJunByu3CSdjXnzYOce9t_0T8BninZsw |
CODEN | NEROEW |
CitedBy_id | crossref_primary_10_1097_JCP_0000000000000590 crossref_primary_10_1111_adb_70020 crossref_primary_10_1093_alcalc_agx119 crossref_primary_10_1038_s41380_022_01594_8 crossref_primary_10_1007_s13311_020_00851_4 crossref_primary_10_1111_acer_12977 crossref_primary_10_1111_acer_14879 crossref_primary_10_1111_adb_12810 crossref_primary_10_1111_adb_13107 crossref_primary_10_9758_cpn_2015_13_1_12 crossref_primary_10_3390_biomedicines9091161 crossref_primary_10_3389_fpsyt_2020_536706 crossref_primary_10_1186_s40810_015_0014_8 crossref_primary_10_1016_j_resp_2017_08_007 crossref_primary_10_1016_j_pbb_2021_173227 crossref_primary_10_1038_s41598_024_81390_2 crossref_primary_10_1111_acer_13931 crossref_primary_10_1523_JNEUROSCI_3383_16_2017 crossref_primary_10_1038_npp_2014_14 crossref_primary_10_1016_j_neulet_2015_11_017 crossref_primary_10_1111_acer_13131 crossref_primary_10_2967_jnumed_119_228825 crossref_primary_10_1172_JCI172884 crossref_primary_10_1080_13543784_2018_1501471 crossref_primary_10_2147_IJGM_S413193 crossref_primary_10_1016_j_drugalcdep_2014_12_028 crossref_primary_10_1111_jgs_12427 crossref_primary_10_1017_S1041610219001418 crossref_primary_10_1111_acer_14816 crossref_primary_10_1111_acer_12758 crossref_primary_10_3389_fneur_2021_641810 crossref_primary_10_1016_j_jns_2020_116763 crossref_primary_10_1111_adb_12238 crossref_primary_10_1111_adb_12635 crossref_primary_10_3390_ijms24054763 crossref_primary_10_1093_ijnp_pyx050 crossref_primary_10_1007_s00213_015_3868_3 crossref_primary_10_1016_j_neuroscience_2024_06_017 crossref_primary_10_1016_j_neuropharm_2023_109515 crossref_primary_10_1016_j_pscychresns_2020_111185 crossref_primary_10_1016_j_ynstr_2024_100657 crossref_primary_10_3390_brainsci11010062 crossref_primary_10_1007_s11432_019_2857_5 crossref_primary_10_1016_j_drugalcdep_2017_06_025 crossref_primary_10_1016_j_neubiorev_2015_11_010 crossref_primary_10_1002_brb3_2804 crossref_primary_10_1111_ner_12405 crossref_primary_10_3390_clinpract14010012 crossref_primary_10_1016_j_neubiorev_2013_06_011 crossref_primary_10_1002_brb3_769 crossref_primary_10_1016_j_nicl_2022_103091 crossref_primary_10_3389_fpsyt_2021_781668 crossref_primary_10_1007_s40473_013_0005_7 crossref_primary_10_1176_appi_ajp_2021_20121757 crossref_primary_10_3389_fpsyt_2018_00412 crossref_primary_10_1016_j_alcohol_2013_11_006 crossref_primary_10_5493_wjem_v15_i1_100402 crossref_primary_10_1016_j_neuroimage_2015_01_014 crossref_primary_10_3389_fnins_2014_00288 crossref_primary_10_2174_1381612826666200406090051 crossref_primary_10_1038_tp_2017_141 crossref_primary_10_1016_j_brainres_2015_01_002 crossref_primary_10_1038_s41537_022_00272_6 crossref_primary_10_1080_1354750X_2022_2049367 crossref_primary_10_1111_acer_12893 crossref_primary_10_1007_s00213_019_05228_w crossref_primary_10_1111_adb_12291 crossref_primary_10_3389_fnins_2017_00686 crossref_primary_10_1002_jnr_24423 crossref_primary_10_51523_2708_6011_2014_11_2_1 crossref_primary_10_1124_pharmrev_121_000361 crossref_primary_10_3174_ajnr_A6632 crossref_primary_10_1016_j_alcohol_2022_08_004 crossref_primary_10_1007_s11432_019_2818_5 crossref_primary_10_1016_j_addicn_2021_100004 crossref_primary_10_1093_alcalc_agz062 crossref_primary_10_1038_s41598_023_29190_y crossref_primary_10_1016_j_neulet_2021_136146 crossref_primary_10_1016_j_pnpbp_2024_111068 crossref_primary_10_1177_0269881119844178 crossref_primary_10_1227_NEU_0000000000001248 crossref_primary_10_12688_f1000research_9609_1 crossref_primary_10_3389_fncel_2016_00265 crossref_primary_10_1523_JNEUROSCI_1821_17_2017 crossref_primary_10_1016_j_neubiorev_2020_03_010 crossref_primary_10_1016_j_pneurobio_2018_10_001 crossref_primary_10_1016_j_neubiorev_2022_104821 crossref_primary_10_1016_j_addicn_2023_100137 crossref_primary_10_1093_alcalc_agad014 crossref_primary_10_3389_fpsyt_2019_00339 crossref_primary_10_1371_journal_pone_0136182 crossref_primary_10_1016_j_euroneuro_2019_09_002 crossref_primary_10_1016_j_alcohol_2021_01_004 crossref_primary_10_1097_JCP_0000000000000786 crossref_primary_10_3389_fphar_2015_00027 crossref_primary_10_1016_j_pscychresns_2021_111329 crossref_primary_10_1038_npp_2013_256 crossref_primary_10_1055_s_0041_1733866 crossref_primary_10_3389_fphar_2014_00158 |
Cites_doi | 10.1097/WNR.0b013e3282ef7625 10.1038/mp.2011.46 10.1016/j.biopsych.2011.07.034 10.1016/j.pnpbp.2011.05.006 10.1111/j.1530-0277.2007.00344.x 10.1038/npp.2011.20 10.1016/j.biopsych.2009.09.016 10.1111/j.1360-0443.1993.tb02093.x 10.1002/mrm.1910300604 10.1016/S0306-4522(99)00250-X 10.1186/1747-597X-6-14 10.1093/alcalc/agr031 10.1016/S0014-2999(99)00209-5 10.1016/j.biopsych.2005.05.038 10.1002/nbm.1772 10.1177/0269881107078308 10.1002/jmri.22638 10.1093/alcalc/agh073 10.1002/mrm.21696 10.1002/jmri.21936 10.1001/archgenpsychiatry.2010.125 10.1001/archpsyc.1996.01830030047008 10.1002/nbm.2831 10.1016/j.addbeh.2004.06.020 10.1111/j.1530-0277.2011.01576.x 10.1037/0021-843X.110.1.40 10.1016/j.neuron.2004.09.016 10.1016/j.biopsych.2009.10.028 10.1152/physrev.00013.2008 10.1016/j.neuroscience.2007.02.016 10.1371/journal.pone.0036572 10.1097/01.ALC.0000167743.96121.40 10.1016/j.neuropharm.2012.02.022 10.1111/j.1749-6632.2009.05143.x 10.1055/s-2007-970144 10.1038/sj.npp.1301033 10.1111/j.1530-0277.1995.tb01475.x 10.1016/S0091-3057(99)00197-5 10.1016/j.ejrad.2009.11.003 10.3389/fnsys.2011.00094 10.1016/j.brainres.2006.11.046 10.1001/archgenpsychiatry.2010.93 10.1196/annals.1300.012 10.1016/j.bcp.2007.06.039 10.1111/j.1749-6632.1999.tb09260.x 10.1093/alcalc/agn100 10.1111/j.1369-1600.2009.00194.x 10.1097/01.ALC.0000150010.72739.58 |
ContentType | Journal Article |
Copyright | 2015 INIST-CNRS Copyright Nature Publishing Group Jul 2013 Copyright © 2013 American College of Neuropsychopharmacology 2013 American College of Neuropsychopharmacology |
Copyright_xml | – notice: 2015 INIST-CNRS – notice: Copyright Nature Publishing Group Jul 2013 – notice: Copyright © 2013 American College of Neuropsychopharmacology 2013 American College of Neuropsychopharmacology |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 88G 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
DOI | 10.1038/npp.2013.45 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Psychology Database Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest One Psychology Neurosciences Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | Glutamatergic dysfunction in alcoholics |
EISSN | 1740-634X |
EndPage | 1408 |
ExternalDocumentID | PMC3682141 2994665261 23403696 27477718 10_1038_npp_2013_45 |
Genre | Journal Article |
GeographicLocations | Germany |
GeographicLocations_xml | – name: Germany |
GroupedDBID | --- -DZ -Q- 0R~ 29N 2WC 36B 39C 4.4 406 5RE 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AANZL AASML AAYXX AAYZH ABAKF ABBRH ABDBE ABFSG ABIVO ABJNI ABLJU ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACMFV ACMJI ACPRK ACRQY ACSTC ACZOJ ADBBV ADFRT AEFQL AEJRE AEMSY AENEX AESKC AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AIXLP AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AOIJS ASPBG ATHPR AVWKF AYFIA AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BPHCQ BVXVI CCPQU CITATION CS3 DIK DNIVK DPUIP DWQXO E3Z EBLON EBS EE. EIOEI EJD EMB EMOBN F5P FDB FDQFY FERAY FIZPM FSGXE FYUFA GNUQQ GX1 HCIFZ HMCUK HYE HZ~ IWAJR JSO JZLTJ KQ8 M1P M2M M7P MK0 NQJWS O9- OK1 P2P P6G PHGZM PHGZT PQQKQ PROAC PSQYO PSYQQ Q2X RNT RNTTT ROL RPM SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TR2 UKHRP W2D ZGI --K 1B1 3V. 53G 5VS AADWK AAEDT AALRI AAPBV AAQFI AAQXK AATNV AAWBL AAXUO AAYFA AAYJO AAZLF ABGIJ ABMAC ABPTK ACBMV ACBRV ACBYP ACIGE ACIUM ACTTH ACVWB ADHDB ADMDM ADMUD ADQMX ADYYL AEDAW AEFTE AFNRJ AGEZK AGGBP AILAN AJCLW AJDOV AMRJV CAG COF FEDTE FGOYB IHE IQODW M41 NAO NQ- NXXTH NYICJ R2- RIG RNS RPZ SEW SSZ ZKB AACDK ABWVN ACRPL ADNMO CGR CUY CVF ECM EIF FIGPU HVGLF LGEZI LOTEE NADUK NPM 7TK 7XB 8FE 8FH 8FK ABRTQ K9. LK8 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c538t-a7d23a5e9748e4d60fbe2ffae306036afff5b99e9752758d35a951ac166d84ae3 |
IEDL.DBID | 7X7 |
ISSN | 0893-133X 1740-634X |
IngestDate | Thu Aug 21 18:21:40 EDT 2025 Mon Jul 21 09:33:36 EDT 2025 Thu Jul 10 23:29:34 EDT 2025 Fri Jul 25 09:15:24 EDT 2025 Thu Apr 03 07:05:49 EDT 2025 Sun Oct 22 16:05:41 EDT 2023 Tue Jul 01 01:05:24 EDT 2025 Thu Apr 24 22:57:18 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Human Poison withdrawal Alcoholism Craving Central nervous system Detoxification Basal ganglion withdrawal Glutamate Encephalon Nucleus accumbens H MRS Alcoholic beverage Cingulate cortex Dependence Excitatory aminoacid Neurotransmitter Disintoxication |
Language | English |
License | http://www.springer.com/tdm CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c538t-a7d23a5e9748e4d60fbe2ffae306036afff5b99e9752758d35a951ac166d84ae3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 These authors contributed equally to this work. |
OpenAccessLink | https://www.nature.com/articles/npp201345.pdf |
PMID | 23403696 |
PQID | 1366949431 |
PQPubID | 33935 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3682141 proquest_miscellaneous_1399919006 proquest_miscellaneous_1367880187 proquest_journals_1366949431 pubmed_primary_23403696 pascalfrancis_primary_27477718 crossref_citationtrail_10_1038_npp_2013_45 crossref_primary_10_1038_npp_2013_45 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-07-01 |
PublicationDateYYYYMMDD | 2013-07-01 |
PublicationDate_xml | – month: 07 year: 2013 text: 2013-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Basingstoke |
PublicationPlace_xml | – name: Basingstoke – name: England – name: New York |
PublicationTitle | Neuropsychopharmacology (New York, N.Y.) |
PublicationTitleAlternate | Neuropsychopharmacology |
PublicationYear | 2013 |
Publisher | Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group |
References | K Moussawi (BFnpp201345_CR33) 2011; 5 R Spanagel (BFnpp201345_CR44) 2009; 89 D Hermann (BFnpp201345_CR19) 2012; 71 GA Miller (BFnpp201345_CR31) 2001; 110 P De Witte (BFnpp201345_CR7) 2004; 29 G Mason (BFnpp201345_CR30) 2005; 29 G Ende (BFnpp201345_CR9) 2005; 58 AE Kelley (BFnpp201345_CR23) 2004; 44 CB Fortier (BFnpp201345_CR10) 2011; 35 GM Khan (BFnpp201345_CR24) 1999; 373 G Mundle (BFnpp201345_CR35) 2006 RF Anton (BFnpp201345_CR3) 1995; 19 PW Kalivas (BFnpp201345_CR22) 2011; 16 PG Mullins (BFnpp201345_CR34) 2008; 60 EM Krupitsky (BFnpp201345_CR25) 2007; 31 F Wang (BFnpp201345_CR47) 2007; 32 JB Saunders (BFnpp201345_CR41) 1993; 88 N Omelchenko (BFnpp201345_CR36) 2007; 146 BFnpp201345_CR8 F Lallemand (BFnpp201345_CR26) 2011; 46 I Hancu (BFnpp201345_CR16) 2009; 30 M Heilig (BFnpp201345_CR17) 2010; 15 GR Siggins (BFnpp201345_CR43) 2003; 1003 RF Anton (BFnpp201345_CR2) 1996; 53 PE Alele (BFnpp201345_CR1) 2005; 29 M Hoerst (BFnpp201345_CR21) 2010; 67 J Gallinat (BFnpp201345_CR11) 2007; 40 Y Mashhoon (BFnpp201345_CR29) 2011; 35 S Modi (BFnpp201345_CR32) 2011; 79 A Dahchour (BFnpp201345_CR6) 2000; 65 SC Licata (BFnpp201345_CR28) 2010; 1187 B Gsellhofer (BFnpp201345_CR15) 1994 ZL Rossetti (BFnpp201345_CR40) 1999; 93 M Gu (BFnpp201345_CR14) 2012; 26 FC Zhou (BFnpp201345_CR51) 2007; 1134 J Besheer (BFnpp201345_CR4) 2010; 67 SW Provencher (BFnpp201345_CR37) 1993; 30 JC Umhau (BFnpp201345_CR46) 2010; 67 RJ Ward (BFnpp201345_CR48) 2009; 44 DL Rothman (BFnpp201345_CR39) 2011; 24 S Roesner (BFnpp201345_CR38) 2008; 22 AS Wijtenburg (BFnpp201345_CR49) 2011; 34 R Thoma (BFnpp201345_CR45) 2011; 36 P Schmidt (BFnpp201345_CR42) 2011; 6 M Heldmann (BFnpp201345_CR18) 2012; 7 NM Zahr (BFnpp201345_CR50) 2010; 67 DJ Hinton (BFnpp201345_CR20) 2012; 62 E Lee (BFnpp201345_CR27) 2007; 18 HJ Groenewegen (BFnpp201345_CR13) 1999; 877 M Bottlender (BFnpp201345_CR5) 2004; 39 JT Gass (BFnpp201345_CR12) 2008; 75 21919920 - Alcohol Clin Exp Res. 2011 Dec;35(12):2193-201 21761460 - J Magn Reson Imaging. 2011 Sep;34(3):645-52 22070867 - Addict Biol. 2013 Mar;18(2):379-91 21519339 - Mol Psychiatry. 2011 Oct;16(10):974-86 21711505 - Subst Abuse Treat Prev Policy. 2011;6:14 20148778 - Addict Biol. 2010 Apr;15(2):169-84 14684447 - Ann N Y Acad Sci. 2003 Nov;1003:196-211 15450168 - Neuron. 2004 Sep 30;44(1):161-79 19342616 - Physiol Rev. 2009 Apr;89(2):649-705 20603446 - Arch Gen Psychiatry. 2010 Sep;67(9):946-54 17198693 - Brain Res. 2007 Feb 23;1134(1):148-61 10415642 - Ann N Y Acad Sci. 1999 Jun 29;877:49-63 20201852 - Ann N Y Acad Sci. 2010 Feb;1187:148-71 19897175 - Biol Psychiatry. 2010 May 1;67(9):812-22 16452988 - Neuropsychopharmacology. 2007 Jan;32(1):103-9 7771669 - Alcohol Clin Exp Res. 1995 Feb;19(1):92-9 20921123 - Arch Gen Psychiatry. 2010 Oct;67(10):1069-77 17374039 - Alcohol Clin Exp Res. 2007 Apr;31(4):604-11 22275885 - Front Syst Neurosci. 2011 Nov 24;5:94 21389979 - Neuropsychopharmacology. 2011 Jun;36(7):1359-65 21478495 - Alcohol Alcohol. 2011 Jul-Aug;46(4):373-82 17712285 - Neuroreport. 2007 Sep 17;18(14):1511-4 17447175 - Pharmacopsychiatry. 2007 Mar;40(2):64-7 8611059 - Arch Gen Psychiatry. 1996 Mar;53(3):225-31 20022190 - Eur J Radiol. 2011 Jul;79(1):96-100 21616118 - Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1709-13 15976529 - Alcohol Clin Exp Res. 2005 Jun;29(6):1027-34 15345268 - Addict Behav. 2004 Sep;29(7):1325-39 17391856 - Neuroscience. 2007 May 25;146(3):1259-74 22616110 - Neuropharmacology. 2012 Jun;62(8):2480-8 8139448 - Magn Reson Med. 1993 Dec;30(6):672-9 19155229 - Alcohol Alcohol. 2009 Mar-Apr;44(2):128-35 11261398 - J Abnorm Psychol. 2001 Feb;110(1):40-8 15895489 - Alcohol Clin Exp Res. 2005 Jan;29(1):150-158 21907974 - Biol Psychiatry. 2012 Jun 1;71(11):1015-21 17706608 - Biochem Pharmacol. 2008 Jan 1;75(1):218-65 18816817 - Magn Reson Med. 2008 Oct;60(4):964-9 10414434 - Eur J Pharmacol. 1999 Jun 4;373(2-3):153-61 21882281 - NMR Biomed. 2011 Oct;24(8):943-57 22629317 - PLoS One. 2012;7(5):e36572 10672989 - Pharmacol Biochem Behav. 2000 Feb;65(2):345-50 18187529 - J Psychopharmacol. 2008 Jan;22(1):11-23 19856449 - J Magn Reson Imaging. 2009 Nov;30(5):1155-62 15208171 - Alcohol Alcohol. 2004 Jul-Aug;39(4):357-61 8329970 - Addiction. 1993 Jun;88(6):791-804 22761057 - NMR Biomed. 2013 Feb;26(2):164-72 20044076 - Biol Psychiatry. 2010 May 1;67(9):846-54 16084857 - Biol Psychiatry. 2005 Dec 15;58(12):974-80 10473277 - Neuroscience. 1999;93(3):1135-40 |
References_xml | – ident: BFnpp201345_CR8 – volume: 18 start-page: 1511 year: 2007 ident: BFnpp201345_CR27 publication-title: Neuroreport doi: 10.1097/WNR.0b013e3282ef7625 – volume: 16 start-page: 974 year: 2011 ident: BFnpp201345_CR22 publication-title: Mol Psychiatry doi: 10.1038/mp.2011.46 – volume: 71 start-page: 1015 year: 2012 ident: BFnpp201345_CR19 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2011.07.034 – volume: 35 start-page: 1709 year: 2011 ident: BFnpp201345_CR29 publication-title: Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2011.05.006 – volume: 31 start-page: 604 year: 2007 ident: BFnpp201345_CR25 publication-title: Alcohol Clin Exp Res doi: 10.1111/j.1530-0277.2007.00344.x – volume: 36 start-page: 1359 year: 2011 ident: BFnpp201345_CR45 publication-title: Neuropsycho-pharmacology doi: 10.1038/npp.2011.20 – volume: 67 start-page: 812 year: 2010 ident: BFnpp201345_CR4 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2009.09.016 – volume: 88 start-page: 791 year: 1993 ident: BFnpp201345_CR41 publication-title: Addiction doi: 10.1111/j.1360-0443.1993.tb02093.x – volume: 30 start-page: 672 year: 1993 ident: BFnpp201345_CR37 publication-title: Magn. Reson. Med doi: 10.1002/mrm.1910300604 – volume: 93 start-page: 1135 year: 1999 ident: BFnpp201345_CR40 publication-title: Neuroscience doi: 10.1016/S0306-4522(99)00250-X – volume: 6 start-page: 14 year: 2011 ident: BFnpp201345_CR42 publication-title: Subst Abuse Treat Prev Policy doi: 10.1186/1747-597X-6-14 – volume: 46 start-page: 373 year: 2011 ident: BFnpp201345_CR26 publication-title: Alcohol Alcohol doi: 10.1093/alcalc/agr031 – volume: 373 start-page: 153 year: 1999 ident: BFnpp201345_CR24 publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(99)00209-5 – volume: 58 start-page: 974 year: 2005 ident: BFnpp201345_CR9 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2005.05.038 – volume: 24 start-page: 943 year: 2011 ident: BFnpp201345_CR39 publication-title: NMR Biomed doi: 10.1002/nbm.1772 – volume: 22 start-page: 11 year: 2008 ident: BFnpp201345_CR38 publication-title: J Psychopharmacol doi: 10.1177/0269881107078308 – volume: 34 start-page: 645 year: 2011 ident: BFnpp201345_CR49 publication-title: J Magnetic Resonance Imaging doi: 10.1002/jmri.22638 – volume: 39 start-page: 357 year: 2004 ident: BFnpp201345_CR5 publication-title: Alcohol Alcohol doi: 10.1093/alcalc/agh073 – volume: 60 start-page: 964 year: 2008 ident: BFnpp201345_CR34 publication-title: Magn Res Med doi: 10.1002/mrm.21696 – volume: 30 start-page: 1155 year: 2009 ident: BFnpp201345_CR16 publication-title: J Magn Reson Imaging doi: 10.1002/jmri.21936 – volume-title: Manual für Training und Durchführung von Interviews mit dem EuropASI year: 1994 ident: BFnpp201345_CR15 – volume: 67 start-page: 1069 year: 2010 ident: BFnpp201345_CR46 publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2010.125 – volume: 53 start-page: 225 year: 1996 ident: BFnpp201345_CR2 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1996.01830030047008 – volume: 26 start-page: 164 year: 2012 ident: BFnpp201345_CR14 publication-title: NMR Biomed doi: 10.1002/nbm.2831 – volume: 29 start-page: 1325 year: 2004 ident: BFnpp201345_CR7 publication-title: Addict Behav doi: 10.1016/j.addbeh.2004.06.020 – volume: 35 start-page: 2193 year: 2011 ident: BFnpp201345_CR10 publication-title: Alcohol Clin Exp Res doi: 10.1111/j.1530-0277.2011.01576.x – volume: 110 start-page: 40 year: 2001 ident: BFnpp201345_CR31 publication-title: J Abnorm Psychol doi: 10.1037/0021-843X.110.1.40 – volume: 44 start-page: 161 year: 2004 ident: BFnpp201345_CR23 publication-title: Neuron doi: 10.1016/j.neuron.2004.09.016 – volume: 67 start-page: 846 year: 2010 ident: BFnpp201345_CR50 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2009.10.028 – volume: 89 start-page: 649 year: 2009 ident: BFnpp201345_CR44 publication-title: Physiol Rev doi: 10.1152/physrev.00013.2008 – volume: 146 start-page: 1259 year: 2007 ident: BFnpp201345_CR36 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2007.02.016 – volume: 7 start-page: e36572 year: 2012 ident: BFnpp201345_CR18 publication-title: PLoS One doi: 10.1371/journal.pone.0036572 – volume: 29 start-page: 1027 year: 2005 ident: BFnpp201345_CR1 publication-title: Alcohol Clin Exp Res doi: 10.1097/01.ALC.0000167743.96121.40 – volume: 62 start-page: 2480 year: 2012 ident: BFnpp201345_CR20 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2012.02.022 – volume: 1187 start-page: 148 year: 2010 ident: BFnpp201345_CR28 publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.2009.05143.x – volume: 40 start-page: 64 year: 2007 ident: BFnpp201345_CR11 publication-title: Pharmacopsychiatry doi: 10.1055/s-2007-970144 – volume: 32 start-page: 103 year: 2007 ident: BFnpp201345_CR47 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301033 – volume: 19 start-page: 92 year: 1995 ident: BFnpp201345_CR3 publication-title: Alcohol Clin Exp Res doi: 10.1111/j.1530-0277.1995.tb01475.x – volume: 65 start-page: 345 year: 2000 ident: BFnpp201345_CR6 publication-title: Pharmacol Biochem Behav doi: 10.1016/S0091-3057(99)00197-5 – volume: 79 start-page: 96 year: 2011 ident: BFnpp201345_CR32 publication-title: Eur J Radiol doi: 10.1016/j.ejrad.2009.11.003 – volume: 5 start-page: 94 year: 2011 ident: BFnpp201345_CR33 publication-title: Front Syst Neurosci doi: 10.3389/fnsys.2011.00094 – volume: 1134 start-page: 148 year: 2007 ident: BFnpp201345_CR51 publication-title: Brain Res doi: 10.1016/j.brainres.2006.11.046 – volume: 67 start-page: 946 year: 2010 ident: BFnpp201345_CR21 publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2010.93 – volume: 1003 start-page: 196 year: 2003 ident: BFnpp201345_CR43 publication-title: Ann N Y Acad Sci doi: 10.1196/annals.1300.012 – start-page: 25 volume-title: Evidenzbasierte Suchtmedizin year: 2006 ident: BFnpp201345_CR35 – volume: 75 start-page: 218 year: 2008 ident: BFnpp201345_CR12 publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2007.06.039 – volume: 877 start-page: 49 year: 1999 ident: BFnpp201345_CR13 publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.1999.tb09260.x – volume: 44 start-page: 128 year: 2009 ident: BFnpp201345_CR48 publication-title: Alcohol Alcohol doi: 10.1093/alcalc/agn100 – volume: 15 start-page: 169 year: 2010 ident: BFnpp201345_CR17 publication-title: Addict Biol doi: 10.1111/j.1369-1600.2009.00194.x – volume: 29 start-page: 150 year: 2005 ident: BFnpp201345_CR30 publication-title: Alcohol Clin Exp Res doi: 10.1097/01.ALC.0000150010.72739.58 – reference: 15345268 - Addict Behav. 2004 Sep;29(7):1325-39 – reference: 15450168 - Neuron. 2004 Sep 30;44(1):161-79 – reference: 21711505 - Subst Abuse Treat Prev Policy. 2011;6:14 – reference: 8139448 - Magn Reson Med. 1993 Dec;30(6):672-9 – reference: 18816817 - Magn Reson Med. 2008 Oct;60(4):964-9 – reference: 21907974 - Biol Psychiatry. 2012 Jun 1;71(11):1015-21 – reference: 14684447 - Ann N Y Acad Sci. 2003 Nov;1003:196-211 – reference: 19856449 - J Magn Reson Imaging. 2009 Nov;30(5):1155-62 – reference: 20201852 - Ann N Y Acad Sci. 2010 Feb;1187:148-71 – reference: 17706608 - Biochem Pharmacol. 2008 Jan 1;75(1):218-65 – reference: 21882281 - NMR Biomed. 2011 Oct;24(8):943-57 – reference: 19342616 - Physiol Rev. 2009 Apr;89(2):649-705 – reference: 20148778 - Addict Biol. 2010 Apr;15(2):169-84 – reference: 17198693 - Brain Res. 2007 Feb 23;1134(1):148-61 – reference: 19155229 - Alcohol Alcohol. 2009 Mar-Apr;44(2):128-35 – reference: 10672989 - Pharmacol Biochem Behav. 2000 Feb;65(2):345-50 – reference: 19897175 - Biol Psychiatry. 2010 May 1;67(9):812-22 – reference: 7771669 - Alcohol Clin Exp Res. 1995 Feb;19(1):92-9 – reference: 22616110 - Neuropharmacology. 2012 Jun;62(8):2480-8 – reference: 10473277 - Neuroscience. 1999;93(3):1135-40 – reference: 15208171 - Alcohol Alcohol. 2004 Jul-Aug;39(4):357-61 – reference: 20044076 - Biol Psychiatry. 2010 May 1;67(9):846-54 – reference: 18187529 - J Psychopharmacol. 2008 Jan;22(1):11-23 – reference: 22070867 - Addict Biol. 2013 Mar;18(2):379-91 – reference: 10414434 - Eur J Pharmacol. 1999 Jun 4;373(2-3):153-61 – reference: 16452988 - Neuropsychopharmacology. 2007 Jan;32(1):103-9 – reference: 21519339 - Mol Psychiatry. 2011 Oct;16(10):974-86 – reference: 17391856 - Neuroscience. 2007 May 25;146(3):1259-74 – reference: 21919920 - Alcohol Clin Exp Res. 2011 Dec;35(12):2193-201 – reference: 17712285 - Neuroreport. 2007 Sep 17;18(14):1511-4 – reference: 10415642 - Ann N Y Acad Sci. 1999 Jun 29;877:49-63 – reference: 22761057 - NMR Biomed. 2013 Feb;26(2):164-72 – reference: 20921123 - Arch Gen Psychiatry. 2010 Oct;67(10):1069-77 – reference: 8611059 - Arch Gen Psychiatry. 1996 Mar;53(3):225-31 – reference: 15976529 - Alcohol Clin Exp Res. 2005 Jun;29(6):1027-34 – reference: 11261398 - J Abnorm Psychol. 2001 Feb;110(1):40-8 – reference: 22275885 - Front Syst Neurosci. 2011 Nov 24;5:94 – reference: 17447175 - Pharmacopsychiatry. 2007 Mar;40(2):64-7 – reference: 20603446 - Arch Gen Psychiatry. 2010 Sep;67(9):946-54 – reference: 21616118 - Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1709-13 – reference: 21389979 - Neuropsychopharmacology. 2011 Jun;36(7):1359-65 – reference: 20022190 - Eur J Radiol. 2011 Jul;79(1):96-100 – reference: 16084857 - Biol Psychiatry. 2005 Dec 15;58(12):974-80 – reference: 22629317 - PLoS One. 2012;7(5):e36572 – reference: 8329970 - Addiction. 1993 Jun;88(6):791-804 – reference: 17374039 - Alcohol Clin Exp Res. 2007 Apr;31(4):604-11 – reference: 21478495 - Alcohol Alcohol. 2011 Jul-Aug;46(4):373-82 – reference: 15895489 - Alcohol Clin Exp Res. 2005 Jan;29(1):150-158 – reference: 21761460 - J Magn Reson Imaging. 2011 Sep;34(3):645-52 |
SSID | ssj0015768 |
Score | 2.4222884 |
Snippet | The upregulation of glutamatergic excitatory neurotransmission is thought to be partly responsible for the acute withdrawal symptoms and craving experienced by... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1401 |
SubjectTerms | Abstinence Addictive behaviors Adult Adult and adolescent clinical studies Alcoholism Alcoholism - diagnosis Alcoholism - metabolism Alcoholism - therapy Alcoholism and acute alcohol poisoning Behavior, Addictive - diagnosis Behavior, Addictive - metabolism Behavior, Addictive - therapy Biological and medical sciences Brain Desintoxication. Drug withdrawal Drug withdrawal Ethanol Female Glutamic Acid - metabolism Gyrus Cinguli - metabolism Humans Hypotheses Magnetic Resonance Spectroscopy - methods Male Medical sciences Metabolism Metabolites Middle Aged Nucleus Accumbens - metabolism Original Physiology Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Spectrum analysis Substance Withdrawal Syndrome - diagnosis Substance Withdrawal Syndrome - metabolism Substance Withdrawal Syndrome - therapy Surveys and Questionnaires Toxicology Treatments |
Title | Craving in Alcohol-Dependent Patients After Detoxification Is Related to Glutamatergic Dysfunction in the Nucleus Accumbens and the Anterior Cingulate Cortex |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23403696 https://www.proquest.com/docview/1366949431 https://www.proquest.com/docview/1367880187 https://www.proquest.com/docview/1399919006 https://pubmed.ncbi.nlm.nih.gov/PMC3682141 |
Volume | 38 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9RAEB60BRGK6FVttB4rSB-ksUk2PzZPEu9aq9DjkBbuLWySDR7o5rzkoPfH-L86s8nlelL6vJOwZCYz38zOzgfwIXdEFmU8tH2vkLavlGtnkcgx50F0mgniXKU65NUkvLzxv8-CWVdwq7u2yo1PNI66qHKqkZ-5PAxjP8Z493nxxybWKDpd7Sg0HsM-jS4jq45mfcLlEpY2KDLmNuZis-5-nsPFmV7QsEqXf6J7THci0sFC1vhxypbV4j7Y-X_35J1wdPEcnnU4kiWt4l_AI6UHcJhozKF_r9kJM52dpmQ-gCdX3QH6AE6m7ajq9Sm73t68qk_NE_0Q6_Uh_B0tJdUa2FyzpKXRtccdYW7Dpu001polRDHOxqqpbqnnyKiZfauZ6bFTBWsq9hVtWyIuVkt0smy8rimUGjl8NcJPNqGRyit8V54TPYmumdSFWUlI6_NqyUa4E-IZU2xEzcG3L-Hm4vx6dGl3VA52jh61sWVUeFwGCrMXofwidMpMeWUpFWYsGENlWZZBFse4HniYwRQ8kAj9ZO6GYSF8FHsFe7rS6ggY5muhQCAqJRmSg3CliDM6es5jT3FPWPBxo8407-acE93Gr9Sct3ORou5T0n3qBxZa60Z40Y73uF9suGMXvSzl9BGGdwuON4aSdk6gTrcma8H7fhl_XzqTkVpVKyMToQt1RfSQDKH4GP2jBa9b29tugPsOUTJaEO1YZS9A48N3V_T8pxkjzkPhub775uGtv4WnnmEAoQ7lY9hrliv1DnFYkw3NzzaE_S_nk-mPf0fHNy4 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIgESQpDyMJSySNADqqnt9WN9QChKKAltoh5aKTd3ba9FJLBD7Ijmx_AX-I3MrO2kQVVvPe_YWmke-83s7HwA7xJLxEHMfdN1Umm6StlmHIgEcx5Ep7EgzlWqQ47G_uDc_TbxJlvwt30LQ22VbUzUgTotEqqRH9rc90M3xPPu8-yXSaxRdLvaUmjUZnGslr8xZSs_Dfuo3_eOc_TlrDcwG1YBM0HnrkwZpA6XnkIgLZSb-lYWKyfLpELwjOFcZlnmxWGI656DYDrlnkQUIhPb91Phohj-9w7cxY1YlOwFk1WCZxN216g15CbmfpPmPaDFxWE-o-GYNv9I76aunIAPZ7JEZWQ1i8Z1MPf_bs0rx9_RY3jU4FbWrQ3tCWypvAM73Rxz9p9Lts90J6ku0Xfg3qi5sO_A_mk9Gnt5wM7WL73KA_3Famj2cgf-9OaSahtsmrNuTdtr9huC3oqd1tNfS9YlSnPWV1VxST1O2qzYsGS6p0-lrCrYV_QliThczTGos_6ypKNby-GvEe6yMY1wXuC_koToUPKSyTzVK12ysmkxZz3cCfGaKdajZuTLp3B-K0p-Btt5kasXwDA_9AUCXynJcC2ER2kY01V3EjqKO8KAD606o6SZq070Hj8ifb_PRYS6j0j3kesZ6B2t8KweJ3K92N6GXaxkqYYQIJwwYLc1lKgJOmW0dhED3q6WMVzQHZDMVbHQMgGGbFsEN8lQ1hBiPDbgeW176w1w1yIKSAOCDatcCdC48s2VfPpdjy3nvnBs135589bfwP3B2egkOhmOj1_BA0ezj1B39C5sV_OFeo0YsIr3tOMxuLhtT_8HvA5zKw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEB2VVKqQEIKWi6GURYI-oJrEXl_WDwiFpKGhNIpQK-XNrO21iAR2iB3RfAw_wtcxs7aTBlV96_OOV5bmsmd2ZucAvI47IvIj7pmOnUjTUcoyI1_EmPMgOo0Eca7SPeTZyDu5cD5P3MkW_G3ewlBbZRMTdaBO8pjuyNsW97zACfC8a6d1W8S4P_gw-2USgxRVWhs6jcpETtXyN6ZvxfthH3X9xrYHx-e9E7NmGDBjdPTSlH5ic-kqBNVCOYnXSSNlp6lUCKQxtMs0Td0oCHDdtRFYJ9yViEhkbHleIhwUw33vwLZPWVELtj8ej8ZfVzUMQvIawwbcxExwUr8O7HDRzmY0KtPi7-gV1ZXz8N5MFqiatOLUuA70_t-7eeUwHDyA-zWKZd3K7B7Clsp2Ya-bYQb_c8kOme4r1Rf2u7BzVpfvd-FwXA3KXh6x8_W7r-JIf7Eaob3cgz-9uaSbDjbNWLci8TX7NV1vycbVLNiCdYngnPVVmV9Sx5M2MjYsmO7wUwkrc_YJPUsiKldzDPGsvyzoINdyuDWCXzaigc4L3CuOiRwlK5jMEr3SJZub5nPWwz8hljPFetSafPkILm5FzY-hleWZegoMs0VPIAyWksy4g2ApCSIqfMeBrbgtDHjbqDOM6ynrRPbxI9TVfi5C1H1Iug8d10BfaYRn1XCR68UONuxiJUs3Cj6CCwP2G0MJ6xBUhGuHMeDVahmDB1WEZKbyhZbxMYBbwr9JhnKIAKOzAU8q21v_AHc6RAhpgL9hlSsBGl6-uZJNv-sh5twTtuVYz27-9Zewg14efhmOTp_DXVtTkVCr9D60yvlCvUBAWEYHtecx-Hbbzv4PHKN4xg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Craving+in+alcohol-dependent+patients+after+detoxification+is+related+to+glutamatergic+dysfunction+in+the+nucleus+accumbens+and+the+anterior+cingulate+cortex&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Bauer%2C+Jochen&rft.au=Pedersen%2C+Anya&rft.au=Scherbaum%2C+Norbert&rft.au=Bening%2C+Johanna&rft.date=2013-07-01&rft.issn=1740-634X&rft.eissn=1740-634X&rft.volume=38&rft.issue=8&rft.spage=1401&rft_id=info:doi/10.1038%2Fnpp.2013.45&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon |